A substance P receptor (NK 1 ) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II

Author： Kingery W.S.   Davies M.F.   Clark J.D.  

Publisher： Elsevier

ISSN： 0304-3959

Source： Pain, Vol.104, Iss.1, 2003-07, pp. : 75-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for local inflammation in complex regional pain syndrome type 1

By Huygen1 Frank J. P. M.   de Bruijn Anke G. J.   de Bruin Martha T.   Groeneweg J. George   Klein Jan   Zijlstra Freek J.  

Mediators of Inflammation, Vol. 11, Iss. 1, 2002-02 ,pp. : 47-51

Informa Healthcare

Access to resources Recommend Favorite

Can complex regional pain syndrome be painless?

By Eisenberg E.   Melamed E.  

Pain, Vol. 106, Iss. 3, 2003-12 ,pp. : 263-267

Elsevier

Access to resources Recommend Favorite

Mirror Therapy in Patients with Causalgia (Complex Regional Pain Syndrome Type II) Following Peripheral Nerve Injury: Two Cases

By Selles Ruud W.   Schreuders Ton A. R.   Stam Henk J.  

Journal of Rehabilitation Medicine, Vol. 40, Iss. 4, 2008-04 ,pp. : 312-314

Medical Journals Limited

Access to resources Recommend Favorite

A Role for Histamine and Substance P in Immediate Allergic Responses in Guinea Pig Airways: Characterization of MDL 108,207DA, a Dual H1 / NK-1 Receptor Antagonist

By  

International Archives of Allergy and Immunology, Vol. 115, Iss. 2, 1998-01 ,pp. : 169-178

Karger

Access to resources Recommend Favorite

Complex regional pain syndrome

By Wilson JG   Serpell MG  

BJA - CEPD Reviews, Vol. 7, Iss. 2, 2007-04 ,pp. : 51-54

Oxford University Press

Access to resources Recommend Favorite